￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The emergence of rubitidine gives patients with small cell lung cancer new hope

2025-10-19 11:44:20

Check Details
Contraindications and precautions for patients with lung cancer taking rupitidine

2025-10-19 11:44:20

Check Details
Small cell lung cancer welcomes new treatment drug: rupitidine

2025-10-19 11:44:20

Check Details
Can trametinib combined with dabrafenib be used to treat mutant advanced NSCLC?

2025-10-19 11:44:20

Check Details
Where can I buy Apellis? What's the price?

2025-10-19 11:44:20

Check Details
The overall response rate of ceritinib (Zanda) in the treatment of lung cancer can reach 72.5%_ Kanghule

2025-10-19 11:44:20

Check Details
Is ceritinib (Zanda) a new option after crizotinib resistance

2025-10-19 11:44:20

Check Details
Alectinib (Anshengsa) What are the advantages of alectinib in treating cancer?

2025-10-19 11:44:20

Check Details
What are the characteristics of DACOMITINIB compared with first-generation drugs?

2025-10-19 11:44:20

Check Details
Safety and effectiveness of crizotinib (Xalkori) in the treatment of advanced or metastatic ROS1-rearranged lung cancer

2025-10-19 11:44:20

Check Details
Efficacy data of Lorlatinib in the treatment of NSCLC patients carrying ALK/ROS1 rearrangements

2025-10-19 11:44:20

Check Details
Efficacy and safety of Lorlatinib

2025-10-19 11:44:20

Check Details
Category
相关知识